[Further development (MDCK) of live cold-adapted influenza vaccine: cultivation of vaccine strains in production fermenters].
Optimal conditions were developed for cultivating the cold-adapted reassortant live influenza vaccine (CARLIV) in MDCK cells, which were in their turn cultivated in fermenters with serum-free medium and microcarrier. The use of MDCK cells meets all national and WHO requirements to continuous cells used in the production of biological preparations. CARLIV cultivated under such conditions well preserve their ts-mutations and mutation, which entail substitutions of amino acids, in all CARLIV genome segments. Provided the cultivation conditions are optimal, the output of multivalent CARLIV in a 101 fermenter can reach 100000 doses.
Gendon
Iu Z
IuZ
Markushin
S G
SG
Akopova
I I
II
Koptiaeva
I B
IB
Nechaeva
E A
EA
Mazurkova
I A
IA
Radaeva
I F
IF
Kolokol'tsova
T D
TD
D000818:Animals; D019149:Bioreactors; D002460:Cell Line; D003080:Cold Temperature; D016895:Culture Media, Serum-Free; D004285:Dogs; D009980:Influenza A virus / Q000235:genetics / Q000254:growth & development*; D007252:Influenza Vaccines / Q000235:genetics / Q000592:standards*; D009154:Mutation; D016865:Reassortant Viruses / Q000235:genetics / Q000254:growth & development*; D014776:Virus Cultivation
D016895:Culture Media, Serum-Free; D007252:Influenza Vaccines